April 6, 2022
A cancer researcher faked data in a grant application, her PhD thesis, and seven published papers, according to the U.S. Office of Research Integrity. Toni Brand, […]
April 4, 2022
The Food and Drug Administration has granted approval to Abbott’s Aveir leadless, single-chamber pacemaker system for patients with bradycardia. In a press release, Abbott said the device […]
April 4, 2022
Karl Storz is recalling more than two dozen models of its urological endoscopes over concerns that the devices may not be adequately cleaned using instructions from […]
April 4, 2022
The US Food and Drug Administration (FDA) has approved the first software to semiautomate anesthesia delivery during surgery. The software, End-tidal (Et) Control, works with General […]
March 29, 2022
The US Food and Drug Administration (FDA) has approved fenfluramine (Fintepla) oral solution, a Schedule IV controlled substance, for the treatment of seizures associated with Lennox-Gastaut […]
March 29, 2022
The US Food and Drug Administration has approved a higher 2-mg dose of the GLP-1 agonist semaglutide (Ozempic, Novo Nordisk) for adults with type 2 diabetes, […]
March 29, 2022
Initiating treatment may become easier for adults living with HIV. The US Food and Drug Administration has approved a label update that allows adults living with […]
March 24, 2022
The US Food and Drug Administration (FDA) has approved a new radioligand treatment for certain men with metastatic castration-resistant prostate cancer (mCRPC), as well as a […]
March 22, 2022
Pfizer is voluntarily recalling some antihypertensive medications because of unacceptable levels of a potential carcinogen, the company announced. The affected products are quinapril HCI/hydrochlorothiazide (Accuretic) tablets that Pfizer distributes, […]